Latest press release

14 . 09 . 2023

Press release

Galderma launches advanced new serum with ALASTIN Skincare® - C-RADICAL Defense Antioxidant Serum

View all

Latest press releases and news stories

Go to news archive

Featured News Article

14/09/2023

News story

Galderma’s World Eczema Week: driving change for the community

Skin condition

14/09/2023

News story

Galderma’s World Eczema Week: driving change for the community

Skin condition

12/09/2023

Press release

Powered by Peptides: Galderma introduces Cetaphil Healthy Renew, a retinol alternative skincare range

U.S. release

29/07/2023

Press release

Galderma reiterates its commitment to commercialize and continue developing the broadest Injectable Aesthetics portfolio on the market, following Ipsen's recent announcement

Global release

27/07/2023

Press release

Galderma achieves record 2 B USD net sales for a six-month period in H1 2023, as it continues to demonstrate leading execution and innovation capabilities in dermatology

Global release

04/07/2023

Press release

Galderma @ WCD 2023: late-breaking phase III results for nemolizumab monotherapy in prurigo nodularis show a significant proportion of itch-free patients by week 4

Global release

28/06/2023

Press release

WCD 2023: Galderma to present extensive data demonstrating enduring commitment to delivering innovative solutions in dermatology

Global release

Galderma Annual reviews

ANNUAL REVIEW 2022

ANNUAL REVIEW 2021

GET IN TOUCH WITH

CHRISTIAN MARCOUX

Chief Communications Officer

christian.marcoux@galderma.com

+41 76 315 26 50

SEBASTIEN CROS

Corporate Communications Director

sebastien.cros@galderma.com

+41 79 529 59 85

JEFF SMITH

Head of U.S. Communications

jeffrey.smith@galderma.com

+1 (682) 401-8428

EMIL IVANOV

Head of Strategy, IR and ESG

emil.ivanov@galderma.com

JESSICA COHEN

Investor Relations & Strategy Director

jessica.cohen@galderma.com

+41 21 642 76 43